Literature DB >> 1740363

Functional loss in age-related Bruch's membrane change with choroidal perfusion defect.

J C Chen1, F W Fitzke, D Pauleikhoff, A C Bird.   

Abstract

During a prospective study of age-related macular degeneration, evidence of diffuse Bruch's membrane disease was sought using fluorescein angiographic evidence of a prolonged choroidal filling phase. Dark-adapted static perimetry was done on eight eyes with this angiographic sign and on six eyes with a similar number of drusen but no manifest choroidal perfusion abnormality. Scotopic threshold was measured using the Humphrey automated perimeter and fine matrix mapping. In eyes without delayed choroidal perfusion, no discrete areas of increased threshold were found compared with the background sensitivity. By contrast, in seven of the eight eyes with fluorescein angiographic evidence of prolonged choroidal filling, discrete areas of scotopic threshold elevation (up to 3.4 log units) were recorded; these corresponded closely to regions of choroidal perfusion abnormality. It was postulated that diffuse deposits of abnormal material might account for both the perfusion abnormality and functional loss by acting as a diffusion barrier between the choriocapillaris and the retinal pigment epithelium.

Entities:  

Mesh:

Year:  1992        PMID: 1740363

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  49 in total

1.  Yellow dye laser thermotherapy of choroidal neovascularisation in age related macular degeneration.

Authors:  M R Beintema; J A Oosterhuis; F Hendrikse
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Effect of niacin on the choroidal circulation of patients with age related macular degeneration.

Authors:  T I Metelitsina; J E Grunwald; J C DuPont; G-S Ying
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 3.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".

Authors:  M Michaelides; G E Holder; A R Webster; D M Hunt; A C Bird; F W Fitzke; J D Mollon; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

5.  Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up.

Authors:  Christina Gerth; Peter B Delahunt; Suhail Alam; Lawrence S Morse; John S Werner
Journal:  Arch Ophthalmol       Date:  2006-03

6.  Morphometric analysis of lipoprotein-like particle accumulation in aging human macular Bruch's membrane.

Authors:  Jiahn-Dar Huang; Christine A Curcio; Mark Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-22       Impact factor: 4.799

7.  Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.

Authors:  Cynthia Owsley; Carrie Huisingh; Gregory R Jackson; Christine A Curcio; Alexander J Szalai; Nassrin Dashti; Mark Clark; Kia Rookard; Mark A McCrory; Tyler T Wright; Michael A Callahan; Lanning B Kline; C Douglas Witherspoon; Gerald McGwin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

8.  Choroidal neovascularisation in age-related macular disease.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

9.  Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration.

Authors:  J F Remulla; A R Gaudio; S Miller; M A Sandberg
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

10.  Congenital stationary night blindness and a "Schubert-Bornschein" type electrophysiology in a family with dominant inheritance.

Authors:  S A Kabanarou; G E Holder; F W Fitzke; A C Bird; A R Webster
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.